Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...
Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...
In December 2025, J.P. Morgan upgraded Recursion Pharmaceuticals after REC-4881 showed rapid, durable polyp burden reductions and a favorable safety profile in familial adenomatous polyposis patients, ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) ranks among the best AI stocks to buy according to analysts. On December 17, ...
Eli Lilly is a well-established pharmaceutical company with a portfolio of products that consistently generate revenue and ...
One of the pioneers in AI-powered drug discovery, Insilico Medicine, has completed an initial public offering (IPO) in Hong ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts.
Wall Street ends 2026 positively with tech stocks dominating, but concerns over valuations drive interest in smaller AI ...
Ethereum Foundation set 2026 zkEVM security targets using soundcalc. ETH also nears a multi month trendline test near $3,030.
Ethereum prioritizes zkEVM security over speed with new 2026 roadmap targeting 128-bit provable security standards.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback